IL111186A - Process for the preparation of microspheres and microspheres made thereby - Google Patents
Process for the preparation of microspheres and microspheres made therebyInfo
- Publication number
- IL111186A IL111186A IL11118694A IL11118694A IL111186A IL 111186 A IL111186 A IL 111186A IL 11118694 A IL11118694 A IL 11118694A IL 11118694 A IL11118694 A IL 11118694A IL 111186 A IL111186 A IL 111186A
- Authority
- IL
- Israel
- Prior art keywords
- microspheres
- preparation
- microspheres made
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/552—Glass or silica
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/10—Magnetic particle immunoreagent carriers the magnetic material being used to coat a pre-existing polymer particle but not being present in the particle core
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
- G01N2446/86—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids the coating being pre-functionalised for attaching immunoreagents, e.g. aminodextran
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
- G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11118694A IL111186A (en) | 1994-10-06 | 1994-10-06 | Process for the preparation of microspheres and microspheres made thereby |
AU41934/96A AU4193496A (en) | 1994-10-06 | 1995-10-05 | Process for the preparation of microspheres and microspheres made thereby |
DE19581787T DE19581787T1 (de) | 1994-10-06 | 1995-10-05 | Verfahren zur Herstellung von Mikrokügelchen und dadurch hergestellte Mikrokügelchen |
US08/809,957 US6103379A (en) | 1994-10-06 | 1995-10-05 | Process for the preparation of microspheres and microspheres made thereby |
PCT/US1995/012988 WO1996011054A2 (en) | 1994-10-06 | 1995-10-05 | Process for the preparation of microspheres and microspheres made thereby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11118694A IL111186A (en) | 1994-10-06 | 1994-10-06 | Process for the preparation of microspheres and microspheres made thereby |
Publications (2)
Publication Number | Publication Date |
---|---|
IL111186A0 IL111186A0 (en) | 1994-12-29 |
IL111186A true IL111186A (en) | 1999-09-22 |
Family
ID=11066612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11118694A IL111186A (en) | 1994-10-06 | 1994-10-06 | Process for the preparation of microspheres and microspheres made thereby |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU4193496A (xx) |
DE (1) | DE19581787T1 (xx) |
IL (1) | IL111186A (xx) |
WO (1) | WO1996011054A2 (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2747669B1 (fr) * | 1996-04-22 | 1998-05-22 | Rhone Poulenc Chimie | Procede de preparation de particules creuses de silice |
CZ297990B6 (cs) | 1997-01-21 | 2007-05-16 | W. R. Grace & Co.-Conn. | Cásticový adsorbent a zpusob jeho výroby |
JP4092070B2 (ja) * | 2000-11-27 | 2008-05-28 | 独立行政法人科学技術振興機構 | 糖誘導体を用いる有機無機複合体および金属酸化物の製造方法 |
GB0107563D0 (en) | 2001-03-27 | 2001-05-16 | Amersham Pharm Biotech Uk Ltd | NO synthase assay particles and method |
US6890703B2 (en) | 2002-03-06 | 2005-05-10 | International Business Machines Corporation | Preparation of crosslinked particles from polymers having activatible crosslinking groups |
US20040197819A1 (en) * | 2003-04-03 | 2004-10-07 | Kimberly-Clark Worldwide, Inc. | Assay devices that utilize hollow particles |
DE10355409A1 (de) | 2003-11-25 | 2005-06-30 | Magnamedics Gmbh | Sphärische, magnetische Silicagel-Träger mit vergrößerter Oberfläche für die Aufreinigung von Nukleinsäuren |
US9278866B2 (en) | 2005-08-10 | 2016-03-08 | The Procter & Gamble Company | Hollow silica particles, compositions comprising them, and methods for making same |
KR101457287B1 (ko) * | 2010-04-20 | 2014-11-04 | 바스프 에스이 | 활성 성분을 포함하는 캡슐 |
WO2014077645A1 (ko) * | 2012-11-16 | 2014-05-22 | 서울대학교산학협력단 | 코드화된 고분자 미세입자 |
DE202016008770U1 (de) * | 2016-03-18 | 2019-08-06 | Bundesrepublik Deutschland, vertreten durch den Bundesminister für Wirtschaft und Energie, dieser vertreten durch den Präsidenten der Bundesanstalt für Materialforschung und –prüfung (BAM) | Hybride Kern-Schale-Mikropartikel umfassend einen Polymerkern und eine Siliziumdioxidschale mit kontrollierter Struktur und Oberfläche |
CN110508222B (zh) * | 2019-08-02 | 2022-03-18 | 复旦大学 | 具有介孔二氧化硅壳层的单分散核壳微球及其制备方法 |
CN113578214B (zh) * | 2021-08-11 | 2023-08-11 | 天津博蕴纯化装备材料科技有限公司 | 微米级多孔磁性微球及其制备方法和应用 |
CN115893980B (zh) * | 2022-09-30 | 2023-08-11 | 安徽华仕新材有限公司 | 一种利用球化剂微粉制备多孔支撑体陶瓷的工艺 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2564336A1 (fr) * | 1984-05-16 | 1985-11-22 | Ohayon Hanania | Dispositif de separation du sang et d'obtention de serum |
FR2624873B1 (fr) * | 1987-12-18 | 1992-01-10 | Rhone Poulenc Chimie | Particules composites magnetisables a base d'organopolysiloxane reticule, leur procede de preparation et leur application en biologie |
WO1992016838A1 (en) * | 1991-03-20 | 1992-10-01 | Gec-Marconi Limited | Separation method |
GB9211822D0 (en) * | 1992-06-04 | 1992-07-15 | Tioxide Group Services Ltd | Composite pigmentary material |
-
1994
- 1994-10-06 IL IL11118694A patent/IL111186A/xx not_active IP Right Cessation
-
1995
- 1995-10-05 AU AU41934/96A patent/AU4193496A/en not_active Abandoned
- 1995-10-05 DE DE19581787T patent/DE19581787T1/de not_active Ceased
- 1995-10-05 WO PCT/US1995/012988 patent/WO1996011054A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
DE19581787T1 (de) | 1997-11-27 |
WO1996011054A3 (en) | 1996-05-23 |
WO1996011054A2 (en) | 1996-04-18 |
IL111186A0 (en) | 1994-12-29 |
AU4193496A (en) | 1996-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9401580D0 (en) | Method for the preparation and popification of alphia - interferon | |
IL116024A0 (en) | Functionalized polyorganisiloxanes and one of the processes for the preparation thereof | |
EP0708482A3 (en) | BiCDMOS manufacturing technology and its structures | |
EP0699695A3 (de) | Verfahren zur Herstellung von Polyacetalcopolymeren | |
IL116025A0 (en) | Functionalized polyorganisiloxanes and one of the processes for the preparation thereof | |
IL113850A0 (en) | Process and intermediates for the preparation of 3-aryluracils | |
EP0761718A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
IL111186A (en) | Process for the preparation of microspheres and microspheres made thereby | |
IL109656A0 (en) | Process for the manufacture of androstane-17-carbothioates and androstane-17-carbothioates prepared thereby | |
KR970000398B1 (en) | Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane | |
GB9509826D0 (en) | Process for the preparation of imidazolutidine | |
EP0761721A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
SG46689A1 (en) | Process for the preparation of 2-h-heptafluoropropane | |
GB9603728D0 (en) | Eggshell catalyst and process for preparation of the same | |
HU216713B (hu) | Ciklusos acetálok és eljárás az előállításukra | |
EP0484546A4 (en) | Microcapsule and method of making the same | |
EP0761719A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
GB9310781D0 (en) | Preparation of microparticles | |
EP0770598A3 (de) | Verfahren zur Herstellung von Carbazaten | |
EP0761720A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
GB9416728D0 (en) | Process for the preparation of 4-chloro-2-cyclopropylcarhbonylaniline | |
IL117191A0 (en) | Process for the preparation of oxazolidinones and their use | |
IL116493A0 (en) | Process for the preparation of sameridine | |
ZA9510894B (en) | Process for the preparation of chloromethylpyridines | |
OA09875A (en) | Deep-drilling cement and process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |